RESEARCH BASE

Search 3,721 documents across 34 fields — every claim tier-rated by evidence

3,721 documents 34 sections 43,623 citations 34,854 keywords indexed 4 evidence tiers

3,633 are the core, quality-scored corpus (34 lettered sections — see How We Work); the remaining 88 are cross-corpus synthesis documents (68 InterDocs, 12 Connections, 8 Theories) also indexed here.

2,198 results for "belief as tool" — page 54 of 110

Z_3_05 Molecular Biology

Z_3_05 — Viral Integration and Endogenous Retroviruses

Approximately 8% of the human genome consists of human endogenous retroviruses (HERVs) — the remnants of ancient retroviral infections that integrated into germline cells and were subsequently inherited vertically like a

endogenous retrovirus ERV HERV viral integration retrovirus reverse transcriptase
Z_2_19 Verified Molecular Biology

Z_2_19 — Senolytics & Geroscience: Targeting Cellular Senescence in Aging

Cellular senescence — the irreversible arrest of cell division first described by Leonard Hayflick and Paul Moorhead (1961, Experimental Cell Research) — has emerged as a central mechanism of aging and age-related diseas

senolytics cellular-senescence geroscience aging-biology senescent-cells sasp
Z_2_10 Molecular Biology

Z_2_10 — Genetics of Aging and Progeria

Aging — the progressive decline in physiological function leading to increased vulnerability to disease and death — has a substantial genetic component: twin studies estimate heritability of human lifespan at ~25–30% (He

aging genetics progeria Hutchinson-Gilford progeria HGPS LMNA lamin A
Z_2_08 Molecular Biology

Z_2_08 — Prion Genetics and Misfolded Proteins

Prions are infectious agents composed entirely of misfolded protein — the only known pathogen that contains no nucleic acid (no DNA, no RNA). The protein-only hypothesis (Stanley Prusiner, 1982 — Nobel Prize 1997) states

prion PRNP PrP PrPSc PrPC prion diseases
Z_2_17 Verified Molecular Biology

Z_2_17 — Prion Biology: Self-Propagating Protein Misfolding and Transmissible Encephalopathies

Prions — proteinaceous infectious particles lacking nucleic acid — represent a paradigm-shattering departure from the central dogma that biological information flows from DNA to RNA to protein. The protein-only hypothesi

prion PrPSc PrPC transmissible spongiform encephalopathy Stanley Prusiner mad cow disease
Z_2_04 Molecular Biology

Z_2_04 — Genetic Disorders and Inborn Errors of Metabolism

Genetic disorders — diseases caused by mutations in single genes (monogenic) or chromosomal abnormalities — affect ~3–5% of live births and collectively represent thousands of distinct conditions catalogued in the Online

genetic disorder inborn error metabolism Mendelian disease sickle cell cystic fibrosis
Z_2_06 Molecular Biology

Z_2_06 — Nutrigenomics and Diet-Gene Interactions

Nutrigenomics — the study of how genetic variation influences nutritional requirements, dietary responses, and disease susceptibility — and its complement nutrigenetics (how diet influences gene expression) represent a r

nutrigenomics nutrigenetics diet-gene interaction lactase persistence alcohol metabolism folate metabolism
Z_2_14 Molecular Biology

Z_2_14 — Genetics of Longevity and Blue Zones

The genetics of human longevity — why some individuals live past 100 while most do not — is a field where heritability is modest, effect sizes are small, and environmental factors dominate, yet several genetic pathways h

longevity genetics aging centenarians Blue Zones telomeres telomerase
Z_2_11 Molecular Biology

Z_2_11 — Genetics of Immunity and MHC Diversity

The major histocompatibility complex (MHC) — known as the human leukocyte antigen (HLA) system in humans — is the most polymorphic gene region in the human genome, encoding cell-surface glycoproteins essential for adapti

major histocompatibility complex MHC HLA human leukocyte antigen adaptive immunity antigen presentation
Z_2_02 Molecular Biology

Z_2_02 — Telomere Biology & Genetics of Aging

Telomeres — repetitive DNA sequences (TTAGGG)ₙ capping the ends of linear chromosomes — serve as protective buffers against chromosome degradation, end-to-end fusion, and the progressive DNA loss inherent in the end-repl

telomere telomerase aging senescence Hayflick limit Elizabeth Blackburn
Z_2_16 Verified Molecular Biology

Z_2_16 — Cancer Genomics & Precision Oncology

Cancer genomics — the comprehensive analysis of the genetic alterations that drive cancer initiation, progression, and resistance to therapy — has transformed oncology from a tissue-of-origin classification system into a

cancer genomics precision oncology tumor sequencing oncogene tumor suppressor somatic mutation
Z_2_05 Molecular Biology

Z_2_05 — Gene Therapy: History and Progress

Gene therapy — the introduction, alteration, or replacement of genetic material within a patient's cells to treat or cure disease — has evolved from a speculative concept to an approved clinical reality over five decades

gene therapy gene replacement viral vector adeno-associated virus AAV lentivirus
Z_2_20 Verified Molecular Biology

Z_2_20 — Prion Molecular Biology

At the molecular level, prion diseases arise from the conversion of the normal cellular prion protein (PrPᶜ) into a misfolded, aggregation-prone conformer (PrPˢᶜ) through a process that remains one of the most extraordin

prion PrP protein misfolding amyloid conformational change PrPSc
Z_2_01 Molecular Biology

Z_2_01 — HLA System & Archaic Immune Inheritance

The Human Leukocyte Antigen (HLA) system is the most polymorphic region of the human genome, encoding cell-surface proteins critical to adaptive immune function. Located on chromosome 6p21.3, the Major Histocompatibility

HLA human leukocyte antigen MHC major histocompatibility complex archaic introgression Denisovan
Z_1_07 Molecular Biology

Z_1_07 — Genetic Recombination and Crossing Over

Genetic recombination — the physical exchange of DNA segments between homologous chromosomes during meiosis — is a fundamental biological process that generates genetic diversity, ensures proper chromosome segregation, a

recombination crossing over meiosis chiasma homologous recombination linkage
Z_1_13 Verified Molecular Biology

Z_1_13 — DNA Repair Mechanisms and Genome Stability

Every human cell sustains an estimated 10,000–100,000 DNA lesions per day from endogenous sources alone — oxidative metabolism, spontaneous hydrolysis, replication errors, and reactive metabolites — while environmental m

DNA repair base excision repair nucleotide excision repair mismatch repair double-strand break homologous recombination
Z_1_17 Verified Molecular Biology

Z_1_17 — Environmental Epigenetics & Toxicogenomics

Environmental epigenetics examines how chemical exposures, nutritional states, and ecological stressors modify gene expression without altering DNA sequence — through DNA methylation, histone modifications, and non-codin

epigenetics toxicogenomics endocrine disruptors PFAS transgenerational inheritance DNA methylation
Z_1_16 Verified Molecular Biology

Z_1_16 — Transposable Elements: Jumping Genes and Genome Evolution

Transposable elements (TEs) — sequences of DNA capable of moving ("jumping") from one genomic location to another — constitute approximately 45% of the human genome and up to 85% of the maize genome, making them the sing

transposable elements jumping genes Barbara McClintock retrotransposons DNA transposons Alu elements
Z_1_04 Molecular Biology

Z_1_04 — Gene Expression and Regulation

Gene expression regulation — the molecular mechanisms controlling when, where, and how much each gene is active — is the central process that enables a single genome to produce ~200 distinct cell types, orchestrate embry

gene expression regulation transcription factors promoter enhancer epigenetics
Z_1_03 Molecular Biology

Z_1_03 — Human Genome Project and Its Legacy

The Human Genome Project (HGP), launched in 1990 and completed in 2003, was the largest coordinated biological research effort in history — a $3 billion, 13-year international collaboration to sequence all ~3.2 billion b

Human Genome Project HGP genome sequencing Francis Collins Craig Venter Celera